Literature DB >> 22675280

Use of protease inhibitors in liver transplant recipients.

Gary L Davis1, Jacqueline G O'Leary.   

Abstract

Year:  2012        PMID: 22675280      PMCID: PMC3365521     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


× No keyword cloud information.
  4 in total

1.  Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.

Authors:  Michael Charlton
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

2.  Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.

Authors:  Varun Garg; Rolf van Heeswijk; Jee Eun Lee; Katia Alves; Priya Nadkarni; Xia Luo
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

Review 3.  Hepatitis C virus treatment pre- and post-liver transplantation.

Authors:  Bruno Roche; Didier Samuel
Journal:  Liver Int       Date:  2012-02       Impact factor: 5.828

Review 4.  Management of recurrent hepatitis C infection after liver transplantation.

Authors:  Alpna R Limaye; Roberto J Firpi
Journal:  Clin Liver Dis       Date:  2011-11       Impact factor: 6.126

  4 in total
  1 in total

Review 1.  Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?

Authors:  Marco Dall'Agata; Annagiulia Gramenzi; Maurizio Biselli; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.